Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paclitaxel Plus Carboplatin (TC) Versus TC Plus Endostar in Patients With Advanced Non-small Cell Lung Cancer(NSCLC): a Randomized, Double-blind, Placebo-controlled, Multicentre Study

NCT00708812 is registered in ClinicalTrials.gov with Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd as lead sponsor.

NCT NCT00708812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00708812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paclitaxel Plus Carboplatin (TC) Versus TC Plus Endostar in Patients With Advanced Non-small Cell Lung Cancer(NSCLC): a Randomized, Double-blind, Placebo-controlled, Multicentre Study
Lead sponsor
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
December 31, 2009
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell lung cancer